Harvard Bioscience approves 2024 cash incentive plan for CEO and CFO

HARVARD BIOSCIENCE INC

Compensation Committee approved 2024 annual cash incentive plan on March 21, 2024.
CEO and CFO each assigned a target award as a percentage of 2024 base salary.
Payout ranges from 0% to 150% of target based on corporate financial objectives.

item 5.02

HARVARD BIOSCIENCE INC filing history →

Source: SEC EDGAR

accession 0001171843-24-001609

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.